We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 27 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 40 actions collected · 40 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 08. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 05. 07. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2026. 05. 07. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2026. 05. 07. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
| 2026. 05. 06. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 05. 06. | Rosenblatt | — | Maintain | Buy → Buy | — | Rosenblatt: Buy |
| 2026. 05. 06. | Needham | — | Maintain | Buy → Buy | — | Needham: Buy |
| 2026. 04. 17. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2026. 04. 07. | Rosenblatt | — | Upgrade | Neutral → Buy | — | Rosenblatt: Neutral → Buy |
| 2026. 03. 31. | Truist Securities | — | Initiate coverage | — → Buy | — | Truist Securities: Buy |
| 2026. 03. 13. | TD Cowen | — | Initiate coverage | — → Buy | — | TD Cowen: Buy |
| 2026. 02. 19. | Needham | — | Maintain | Buy → Buy | — | Needham: Buy |
| 2026. 02. 14. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2026. 02. 14. | Goldman Sachs | — | Maintain | Buy → Buy | — | Goldman Sachs: Buy |
| 2026. 02. 14. | Evercore ISI Group | — | Maintain | Outperform → Outperform | — | Evercore ISI Group: Outperform |
| 2026. 02. 14. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 02. 14. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 02. 13. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 02. 13. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2026. 02. 13. | Rosenblatt | — | Maintain | Neutral → Neutral | — | Rosenblatt: Neutral |
| 2026. 02. 13. | Needham | — | Maintain | Buy → Buy | — | Needham: Buy |
| 2026. 02. 10. | Rosenblatt | — | Maintain | Neutral → Neutral | — | Rosenblatt: Neutral |
| 2026. 01. 06. | Piper Sandler | — | Upgrade | Neutral → Overweight | — | Piper Sandler: Neutral → Overweight |
| 2025. 12. 17. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2025. 11. 06. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 11. 06. | Piper Sandler | — | Maintain | Neutral → Neutral | — | Piper Sandler: Neutral |
| 2025. 11. 05. | Rosenblatt | — | Maintain | Neutral → Neutral | — | Rosenblatt: Neutral |
| 2025. 10. 10. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2025. 09. 16. | Needham | — | Maintain | Buy → Buy | — | Needham: Buy |
| 2025. 09. 13. | Melius Research | — | Maintain | Buy → Buy | — | Melius Research: Buy |
| 2025. 09. 13. | Goldman Sachs | — | Maintain | Buy → Buy | — | Goldman Sachs: Buy |
| 2025. 09. 13. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2025. 09. 12. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2025. 09. 12. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2025. 09. 12. | Evercore ISI Group | — | Maintain | Outperform → Outperform | — | Evercore ISI Group: Outperform |
| 2025. 09. 12. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 09. 12. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2025. 09. 12. | Rosenblatt | — | Maintain | Neutral → Neutral | — | Rosenblatt: Neutral |
| 2025. 09. 12. | Wolfe Research | — | Maintain | Outperform → Outperform | — | Wolfe Research: Outperform |
| 2025. 09. 04. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |